Correction to: Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice (Diabetologia, (2015), 58, 1, (122-131), 10.1007/s00125-014-3413-7);Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice

Diabetologia

Volumn 58, Issue 1, 2015, Pages 122-131

  Xi, Yannan ^a   Liu, Siming ^a   Bettaieb, Ahmed ^a   Matsuo, Kosuke ^a   Matsuo, Izumi ^a   Hosein, Ellen ^a   Chahed, Samah ^a   Wiede, Florian ^b   Zhang, Sheng ^c   Zhang, Zhong Yin ^c   Kulkarni, Rohit N ^d   Tiganis, Tony ^b   Haj, Fawaz G ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONASH UNIVERSITY   (Australia)

^c INDIANA UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Insulin secretion; Ptpn2; STAT1; STAT3; T cell protein tyrosine phosphatase; Type 2 diabetes

Indexed keywords

CELL PROTEIN; GLUCOSE; INSULIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PANCREATIC T CELL PROTEIN; PROTEIN TYROSINE PHOSPHATASE; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME DEFICIENCY; EX VIVO STUDY; FAT INTAKE; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PROTEIN PHOSPHORYLATION; TYROSINE PHOSPHATASE DEFICIENCY; ANIMAL; CELL CULTURE; FEMALE; GENETICS; GLUCOSE INTOLERANCE; KNOCKOUT MOUSE; LIPID DIET; MALE; METABOLISM; PANCREAS; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CELLS, CULTURED; DIET, HIGH-FAT; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, KNOCKOUT; PANCREAS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; STAT3 TRANSCRIPTION FACTOR;

EID: 84916597614     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-023-06023-1     Document Type: Erratum

References (50)

1. Biddinger SB, Kahn CR (2006) From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123–158
2. Michael MD, Kulkarni RN, Postic C et al (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97
3. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339
4. Kulkarni RN, Holzenberger M, Shih DQ et al (2002) beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 31:111–115
5. Tiganis T, Bennett AM (2007) Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402:1–15
6. Tiganis T, Bennett AM, Ravichandran KS, Tonks NK (1998) Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T cell protein tyrosine phosphatase. Mol Cell Biol 18:1622–1634
7. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT et al (2003) Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23:2096–2108
8. van Vliet C, Bukczynska PE, Puryer MA et al (2005) Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol 6:253–260
9. Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ (2002) The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 12:446–453
10. Fukushima A, Loh K, Galic S, et al T cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes 59:1906-1914
11. ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y et al (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 22:5662–5668
12. Aoki N, Matsuda T (2002) A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol 16:58–69
13. Lu X, Chen J, Sasmono RT et al (2007) T cell protein tyrosine phosphatase, distinctively expressed in activated-B cell-like diffuse large B cell lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol 27:2166–2179
14. You-Ten KE, Muise ES, Itie A et al (1997) Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186:683–693
15. Wiede F, Shields BJ, Chew SH et al (2011) T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Investig 121:4758–4774
16. Loh K, Merry TL, Galic S et al (2012) T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice. Diabetologia 55:468–478
17. Loh K, Fukushima A, Zhang X et al (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14:684–699
18. Gurzov EN, Tran M, Fernandez-Rojo MA et al (2014) Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. Cell Metab 20:85–102
19. Moore F, Colli ML, Cnop M et al (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis. Diabetes 58:1283–1291
20. Santin I, Moore F, Colli ML et al (2011) PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic beta-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 60:3279–3288
21. Ize-Ludlow D, Lightfoot YL, Parker M et al (2011) Progressive erosion of beta-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Diabetes 60:2086–2091
22. Bettaieb A, Liu S, Xi Y et al (2011) Differential regulation of endoplasmic reticulum stress by protein tyrosine phosphatase 1B and T cell protein tyrosine phosphatase. J Biol Chem 11:9225–9235
23. Bettaieb A, Xi Y, Hosein E et al (2014) Pancreatic T cell protein-tyrosine phosphatase deficiency ameliorates cerulein-induced acute pancreatitis. Cell Commun Signal 12:13
24. Liu S, Xi Y, Bettaieb A, et al (2014) Disruption of protein-tyrosine phosphatase 1B expression in the pancreas affects beta-cell function. Endocrinology: en20132004
25. Zhang S, Chen L, Luo Y, Gunawan A, Lawrence DS, Zhang ZY (2009) Acquisition of a potent and selective TC-PTP inhibitor via a stepwise fluorophore-tagged combinatorial synthesis and screening strategy. J Am Chem Soc 131:13072–13079
26. Zhang X, Yue P, Page BD et al (2012) Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci U S A 109:9623–9628
27. Guillam MT, Hummler E, Schaerer E et al (1997) Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 17:327–330
28. Hani EH, Stoffers DA, Chevre JC et al (1999) Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Investig 104:R41–R48
29. Aizawa T, Asanuma N, Terauchi Y et al (1996) Analysis of the pancreatic beta cell in the mouse with targeted disruption of the pancreatic beta cell-specific glucokinase gene. Biochem Biophys Res Commun 229:460–465
30. Leroux L, Desbois P, Lamotte L et al (2001) Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50(Suppl 1):S150–S153
31. Wang J, Takeuchi T, Tanaka S et al (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Investig 103:27–37
32. Gupta RK, Vatamaniuk MZ, Lee CS et al (2005) The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J Clin Investig 115:1006–1015
33. Namkung Y, Skrypnyk N, Jeong MJ et al (2001) Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. J Clin Investig 108:1015–1022
34. Fukushima A, Loh K, Galic S et al (2010) T cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes 59:1906–1914
35. Schindler C, Levy DE, Decker T (2007) JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282:20059–20063
36. Wicksteed B, Brissova M, Yan W et al (2010) Conditional gene targeting in mouse pancreatic ss-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59:3090–3098
37. Kushner JA, Haj FG, Klaman LD et al (2004) Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes 53:61–66
38. Zhang SS, Hao E, Yu J et al (2009) Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic beta-cells. Proc Natl Acad Sci U S A 106:7531–7536
39. Mekada K, Abe K, Murakami A et al (2009) Genetic differences among C57BL/6 substrains. Exp Anim / Japan Assoc Lab Anim Sci 58:141–149
40. Merry TL, Tran M, Stathopoulos M et al (2014) High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage. Antioxid Redox Signal 20:2114–2129
41. Kido Y, Burks DJ, Withers D et al (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Investig 105:199–205
42. Yaekura K, Julyan R, Wicksteed BL et al (2003) Insulin secretory deficiency and glucose intolerance in Rab3A null mice. J Biol Chem 278:9715–9721
43. Gorogawa S, Fujitani Y, Kaneto H et al (2004) Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. Biochem Biophys Res Commun 319:1159–1170
44. Cui Y, Huang L, Elefteriou F et al (2004) Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol 24:258–269
45. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M (2000) Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 26:139–142
46. Lee JY, Hennighausen L (2005) The transcription factor Stat3 is dispensable for pancreatic beta-cell development and function. Biochem Biophys Res Commun 334:764–768
47. Kostromina E, Gustavsson N, Wang X et al (2010) Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas. Endocrinology 151:2050–2059
48. Kim S, Kim HS, Chung KW et al (2007) Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Diabetes 56:2561–2568
49. Moore F, Naamane N, Colli ML et al (2011) STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation. J Biol Chem 286:929–941
50. Shields BJ, Court NW, Hauser C, Bukczynska PE, Tiganis T (2008) Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signalling by the protein tyrosine phosphatase TCPTP. Cell Cycle 7:3405–3416